- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03342274
Adapting the Diabetes Prevention Program for a Developing World Context
May 12, 2022 updated by: Children's Mercy Hospital Kansas City
This study will examine whether an adapted version of ]he Diabetes Prevention Program (DPP) can be effective when delivered by community health workers (CHWs) in a poor urban community in South Africa.
We will randomize existing groups that are part of an non-governmental organization's (NGO) chronic disease management program (anticipated cluster N = 54; anticipated individual N=540), to receive either the program or usual care (wait-list).
The primary outcome analysis will compare percentage of baseline weight loss at Y1 between the program and usual care; however, after Y1 usual care participants will also receive the program and both groups will be followed for another year.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
494
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cape Town, South Africa
- University of the Western Cape
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- member of participating partner NGO "health club" (members are medically stabilized individuals with diabetes mellitus or hypertension referred for disease and lifestyle management)
- BMI greater than or equal to 25 kg per meter squared
Exclusion Criteria:
- unsafe level of blood pressure (greater than or equal to 160 (systolic) and greater than equal to 100 mm (diastolic)) at screening
- elevated blood sugar (A1C greater than 11) at screening
- being pregnant, breast-feeding or planning pregnancy within 2 years
- chronic use of oral steroid medication
- intellectual disabilities that would prevent ability to understand the program
- not intending to stay in the health club over the next 2 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lifestyle Program Intervention
Participants receive usual care and group weight loss sessions adapted from the Diabetes Prevention Program delivered by Community Health Workers.
|
Participants will receive group weight loss sessions addressing healthy eating, exercise, and weight loss principles adapted from the Diabetes Prevention Program delivered by Community Health Workers.
Usual care consists of chronic disease management through medication delivery and monitoring of weight, blood pressure, and blood glucose by Community Health Workers.
|
Other: Wait list
Participants receive usual care and after 1 year receive the Lifestyle Program intervention
|
Usual care consists of chronic disease management through medication delivery and monitoring of weight, blood pressure, and blood glucose by Community Health Workers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight loss
Time Frame: 1 year
|
percentage weight loss (weight measured in kilograms)
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood pressure
Time Frame: 1 year
|
systolic blood pressure (mmHG), diastolic blood pressure (mmHG)
|
1 year
|
HbA1c
Time Frame: 1 year
|
percent
|
1 year
|
LDL cholesterol
Time Frame: 1 year
|
mg/dl
|
1 year
|
Triglycerides
Time Frame: 1 year
|
mg/dl
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Catley D, Puoane T, Tsolekile L, Resnicow K, Fleming KK, Hurley EA, Smyth JM, Materia FT, Lambert EV, Vitolins MZ, Levitt NS, Goggin K. Evaluation of an adapted version of the Diabetes Prevention Program for low- and middle-income countries: A cluster randomized trial to evaluate "Lifestyle Africa" in South Africa. PLoS Med. 2022 Apr 15;19(4):e1003964. doi: 10.1371/journal.pmed.1003964. eCollection 2022 Apr.
- Catley D, Puoane T, Tsolekile L, Resnicow K, Fleming K, Hurley EA, Smyth JM, Vitolins MZ, Lambert EV, Levitt N, Goggin K. Adapting the Diabetes Prevention Program for low and middle-income countries: protocol for a cluster randomised trial to evaluate 'Lifestyle Africa'. BMJ Open. 2019 Nov 11;9(11):e031400. doi: 10.1136/bmjopen-2019-031400.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 16, 2018
Primary Completion (Actual)
November 13, 2019
Study Completion (Actual)
December 17, 2019
Study Registration Dates
First Submitted
November 10, 2017
First Submitted That Met QC Criteria
November 10, 2017
First Posted (Actual)
November 14, 2017
Study Record Updates
Last Update Posted (Actual)
May 13, 2022
Last Update Submitted That Met QC Criteria
May 12, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15080328
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight Loss
-
United States Army Research Institute of Environmental...USDA Grand Forks Human Nutrition Research Center; Eastern Michigan UniversityCompletedWeight Loss | Bone Loss | Muscle LossUnited States
-
Case Comprehensive Cancer CenterUniversity Hospitals Seidman Cancer CenterRecruitingUnintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking CombinUnintended Weight LossUnited States
-
Zhen Jun WangUnknownSleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Jejunojejunal Bypass | UncutChina
-
HealthPartners InstituteNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
Medical University of ViennaCompleted
-
Power Life Sciences Inc.Not yet recruitingGastric Bypass | Weight Loss Surgery
-
University at BuffaloHarvard Medical School (HMS and HSDM)TerminatedWeight Loss | Appetite LossUnited States
-
Duke UniversityNational Institute on Aging (NIA)Suspended
-
Drexel UniversityUniversity of PennsylvaniaCompletedObesity | Overweight | Weight Loss MaintenanceUnited States
Clinical Trials on Lifestyle Program
-
Azienda Ospedaliero-Universitaria CareggiRecruitingDiabetes Mellitus, Type 2Italy
-
Scripps Center for Integrative MedicineUnknown
-
Medical College of WisconsinLoyola University ChicagoCompletedBreast Cancer | Gynecologic CancerUnited States
-
Boston Heart DiagnosticsHeart Fit for Duty, LLCCompleted
-
Sheba Medical CenterD-Cure, Israel; Rashi FoundationCompleted
-
Universitair Ziekenhuis BrusselTerminatedPolycystic Ovarian Syndrome | Infertility, Female | LifestyleBelgium
-
Federal University of Juiz de ForaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Federal University... and other collaboratorsRecruitingDiabetes Mellitus | PrediabetesBrazil
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedLung Diseases, Obstructive | Pulmonary Disease, Chronic ObstructiveUnited States
-
University of the Basque Country (UPV/EHU)Universidad Pública de Navarra; Ministerio de Economía y Competitividad, SpainCompletedOverweight Children With Type 2 Diabetes RiskSpain
-
Instituto de Investigación Sanitaria AragónCompleted